Deranged myofilament phosphorylation and function in experimental heart failure with preserved ejection fraction

Cardiovascular Research

Volumn 97, Issue 3, 2013, Pages 464-471

  Hamdani, Nazha ^a   Bishu, Kalkidan G ^b   Von Frieling Salewsky, Marion ^a   Redfield, Margaret M ^b   Linke, Wolfgang A ^a  

^a RUHR UNIVERSITY BOCHUM   (Germany)

^b MAYO CLINIC   (United States)

Author keywords

Diastolic heart failure; Hypertrophy; Passive stiffness; Titin

Indexed keywords

CONNECTIN; CYCLIC AMP DEPENDENT PROTEIN KINASE; CYCLIC GMP DEPENDENT PROTEIN KINASE; GLUTAMIC ACID; LYSINE; MYOSIN LIGHT CHAIN 2; PHOSPHATASE; PROLINE; PROTEIN KINASE C ALPHA; SERINE; TROPONIN I; TROPONIN T; VALINE;

ANIMAL EXPERIMENT; ANIMAL MODEL; ARTICLE; CONTROLLED STUDY; DIASTOLIC DYSFUNCTION; ENZYME ACTIVITY; HEART FAILURE; HEART FAILURE WITH PRESERVED EJECTION FRACTION; HEART LEFT VENTRICLE FUNCTION; HEART LEFT VENTRICLE HYPERTROPHY; HEART MUSCLE CELL; HYPERTENSION; NONHUMAN; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION;

AGING; ANIMALS; CALCIUM; CARDIAC MYOSINS; CELLS, CULTURED; CYCLIC AMP-DEPENDENT PROTEIN KINASES; CYCLIC GMP-DEPENDENT PROTEIN KINASES; DISEASE MODELS, ANIMAL; DOGS; HEART FAILURE; HEART VENTRICLES; MUSCLE PROTEINS; MYOCYTES, CARDIAC; MYOFIBRILS; MYOSIN LIGHT CHAINS; PHOSPHORYLATION; PROTEIN KINASES; STROKE VOLUME;

EID: 84874264782     PISSN: 00086363     EISSN: 17553245     Source Type: Journal    
DOI: 10.1093/cvr/cvs353     Document Type: Article

References (40)

1. Bursi F, Weston SA, Redfield MM, Jacobsen SJ, Pakhomov S, Nkomo VT et al. Systolic and diastolic heart failure in the community. JAMA 2006;296:2209-2216.
2. Paulus WJ, Tschope C, Sanderson JE, Rusconi C, Flachskampf FA, Rademakers FE et al. How to diagnose diastolic heart failure: a consensus statement on the diagnosis of heart failure with normal left ventricular ejection fraction by the Heart Failure and Echocardiography Associations of the European Society of Cardiology. Eur Heart J 2007;28:2539-2550.
3. Zile MR, Baicu CF, Gaasch WH. Diastolic heart failure-abnormalities in active relaxation and passive stiffness of the left ventricle. N Engl J Med 2004;350:1953-1959.
4. Martos R, Baugh J, Ledwidge M, O'Loughlin C, Conlon C, Patle A et al. Diastolic heart failure: evidence of increased myocardial collagen turnover linked to diastolic dysfunction. Circulation 2007;115:888-895.
5. Linke WA. Sense and stretchability: The role of titin and titin-associated proteins in myocardial stress-sensing and mechanical dysfunction. Cardiovasc Res 2008;77: 637-648.
6. van Heerebeek L, Borbely A, Niessen HW, Bronzwaer JG, Van der Velden J, Stienen GJ et al. Myocardial structure and function differ in systolic and diastolic heart failure. Circulation 2006;113:1966-1973.
7. Borbely A, Falcao-Pires I, van Heerebeek L, Hamdani N, Edes I, Gavina C et al. Hypophosphorylation of the stiff N2B titin isoform raises cardiomyocyte resting tension in failing human myocardium. Circ Res 2009;104:780-786.
8. Freiburg A, Trombitas K, HellW, Cazorla O, Fougerousse F, Centner T et al. Series of exon-skipping events in the elastic spring region of titin as the structural basis for myofibrillar elastic diversity. Circ Res 2000;86:1114-1121.
9. Neagoe C, Kulke M, del Monte F, Gwathmey JK, de Tombe PP, Hajjar RJ et al. Titin isoform switch in ischemic human heart disease. Circulation 2002;106:1333-1341.
10. Nagueh SF, Shah G, Wu Y, Torre-Amione G, King NM, Lahmers S et al. Altered titin expression, myocardial stiffness, and left ventricular function in patients with dilated cardiomyopathy. Circulation 2004;110:155-162.
11. Makarenko I, Opitz CA, Leake MC, Neagoe C, Kulke M, Gwathmey JK et al. Passive stiffness changes caused by upregulation of compliant titin isoforms in human dilated cardiomyopathy hearts. Circ Res 2004;95:708-716.
12. Yamasaki R, Wu Y, McNabb M, Greaser M, Labeit S, Granzier H. Protein kinase A phosphorylates titin's cardiac-specific N2B domain and reduces passive tension in rat cardiac myocytes. Circ Res 2002;90:1181-1188.
13. Kruger M, Linke WA. Protein kinase-A phosphorylates titin in human heart muscle and reduces myofibrillar passive tension. J Muscle Res Cell Motil 2006;27:435-444.
14. Kruger M, Kotter S, Grutzner A, Lang P, Andresen C, Redfield MM et al. Protein kinase G modulates human myocardial passive stiffness by phosphorylation of the titin springs. Circ Res 2009;104:87-94.
15. Bishu K, Hamdani N, Mohammed SF, Kruger M, Ohtani T, Ogut O et al. Sildenafil and B-type natriuretic peptide acutely phosphorylate titin and improve diastolic distensibility in vivo. Circulation 2011;124:2882-2891.
16. Hidalgo C, Hudson B, Bogomolovas J, Zhu Y, Anderson B, Greaser M et al. PKC phosphorylation of titin's PEVK element: a novel and conserved pathway for modulating myocardial stiffness. Circ Res 2009;105:631-638.
17. Belin RJ, Sumandea MP, Allen EJ, Schoenfelt K, Wang H, Solaro RJ et al. Augmented protein kinase C-alpha-induced myofilament protein phosphorylation contributes to myofilament dysfunction in experimental congestive heart failure. Circ Res 2007;101: 195-204.
18. Hudson B, Hidalgo C, Saripalli C, Granzier H. Hyperphosphorylation of mouse cardiac titin contributes to transverse aortic constriction-induced diastolic dysfunction. Circ Res 2011;109:858-866.
19. Kobayashi T, Jin L, de Tombe PP. Cardiac thin filament regulation. Pflugers Arch 2008; 457:37-46.
20. Hamdani N, Kooij V, van Dijk S, Merkus D, Paulus WJ, Remedios CD et al. Sarcomeric dysfunction in heart failure. Cardiovasc Res 2008;77:649-658.
21. Solaro RJ, Kobayashi T. Protein phosphorylation and signal transduction in cardiac thin filaments. J Biol Chem 2011;286:9935-9940.
22. Burkart EM, Sumandea MP, Kobayashi T, Nili M, Martin AF, Homsher E et al. Phosphorylation or glutamic acid substitution at protein kinase C sites on cardiac troponin I differentially depress myofilament tension and shortening velocity. J Biol Chem 2003; 278:11265-11272.
23. Belin RJ, Sumandea MP, Kobayashi T, Walker LA, Rundell VL, Urboniene D et al. Left ventricular myofilament dysfunction in rat experimental hypertrophy and congestive heart failure. Am J Physiol Heart Circ Physiol 2006;291:H2344-H2353.
24. Marston SB, de Tombe PP. Troponin phosphorylation and myofilament Ca2+-sensitivity in heart failure: increased or decreased? J Mol Cell Cardiol 2008;45:603-607.
25. Hamdani N, de Waard M, Messer AE, Boontje NM, Kooij V, van Dijk S et al. Myofilament dysfunction in cardiac disease from mice to men. J Muscle Res Cell Motil 2008;29: 189-201.
26. Solaro RJ, van der Velden J. Why does troponin I have so many phosphorylation sites? Fact and fancy. J Mol Cell Cardiol 2010;48:810-816.
27. Dong X, Sumandea CA, Chen YC, Garcia-Cazarin ML, Zhang J, Balke CW et al. Augmented phosphorylation of cardiac troponin I in hypertensive heart failure. J Biol Chem 2012;287:848-857.
28. Munagala VK, Hart CY, Burnett JC Jr, Meyer DM, Redfield MM. Ventricular structure and function in aged dogs with renal hypertension: a model of experimental diastolic heart failure. Circulation 2005;111:1128-1135.
29. Hamdani N, Paulus WJ, van Heerebeek L, Borbely A, Boontje NM, Zuidwijk MJ et al. Distinct myocardial effects of beta-blocker therapy in heart failure with normal and reduced left ventricular ejection fraction. Eur Heart J 2009;30:1863-1872.
30. Shapiro BP, Lam CS, Patel JB, Mohammed SF, Kruger M, Meyer DM et al. Acute and chronic ventricular-arterial coupling in systole and diastole: insights from an elderly hypertensive model. Hypertension 2007;50:503-511.
31. Strang KT, Sweitzer NK, Greaser ML, Moss RL. Beta-adrenergic receptor stimulation increases unloaded shortening velocity of skinned single ventricular myocytes from rats. Circ Res 1994;74:542-549.
32. Bristow MR, Ginsburg R, Umans V, Fowler M, Minobe W, Rasmussen R et al. Beta 1-and beta 2-adrenergic-receptor subpopulations in nonfailing and failing human ventricular myocardium: coupling of both receptor subtypes to muscle contraction and selective beta 1-receptor down-regulation in heart failure. Circ Res 1986;59: 297-309.
33. Lee DI, Vahebi S, Tocchetti CG, Barouch LA, Solaro RJ, Takimoto E et al. PDE5A suppression of acute beta-adrenergic activation requires modulation of myocyte beta-3 signaling coupled to PKG-mediated troponin I phosphorylation. Basic Res Cardiol 2010;105:337-347.
34. Wu Y, Bell SP, Trombitas K, Witt CC, Labeit S, LeWinter MM et al. Changes in titin isoform expression in pacing-induced cardiac failure give rise to increased passive muscle stiffness. Circulation 2002;106:1384-1389.
35. Jaber WA, Maniu C, Krysiak J, Shapiro BP, Meyer DM, Linke WA et al. Titin isoforms, extracellular matrix, and global chamber remodeling in experimental dilated cardiomyopathy: functional implications and mechanistic insight. Circ Heart Fail 2008;1: 192-199.
36. Williams L, Howell N, Pagano D, Andreka P, Vertesaljai M, Pecor T et al. Titin isoform expression in aortic stenosis. Clin Sci (Lond) 2009;117:237-242.
37. Hoskins AC, Jacques A, Bardswell SC, McKenna WJ, Tsang V, dos Remedios CG et al. Normal passive viscoelasticity but abnormal myofibrillar force generation in human hypertrophic cardiomyopathy. J Mol Cell Cardiol 2010;49:737-745.
38. Warren CM, Jordan MC, Roos KP, Krzesinski PR, Greaser ML. Titin isoform expression in normal and hypertensive myocardium. Cardiovasc Res 2003;59:86-94.
39. Borbely A, van der Velden J, Papp Z, Bronzwaer JG, Edes I, Stienen GJ et al. Cardiomyocyte stiffness in diastolic heart failure. Circulation 2005;111:774-781.
40. van Heerebeek L, Hamdani N, Handoko ML, Falcao-Pires I, Musters RJ, Kupreishvili K et al. Diastolic stiffness of the failing diabetic heart: importance of fibrosis, advanced glycation end products, and myocyte resting tension. Circulation 2008;117:43-51.